Bill
Bill > HR1332
US HR1332
To address the high costs of health care services, prescription drugs, and health insurance coverage in the United States, and for other purposes.
summary
Introduced
02/25/2019
02/25/2019
In Committee
02/26/2019
02/26/2019
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
116th Congress
Bill Summary
Addresses the health care system, including Medicare, Medicaid, the private health insurance market, and the prescription drug approval process. The bill also revises tax provisions related to certain health care costs and establishes requirements for lawsuits involving health care provided, at least in part, through a federal program or with federal funds.
AI Summary
This bill aims to address the high costs of health care services, prescription drugs, and health insurance coverage in the United States through a variety of reforms across the private insurance market, Medicare and Medicaid programs, and prescription drug competition.
Key provisions include:
- Establishing an "Invisible High Risk Pool Reinsurance Program" to help stabilize the individual insurance market and imposing a tax on health plans sold through the ACA exchanges.
- Changing the permissible age variation in health insurance premium rates.
- Repealing the employer health insurance mandate.
- Providing greater flexibility for states to obtain waivers under the ACA.
- Limiting exclusivity periods for drugs treating rare diseases and biosimilar products.
- Requiring the FDA to expedite development and priority review of generic complex drug products.
- Repealing the limit on the maximum Medicaid rebate amount for single source and innovator multiple source drugs.
- Regulating manufacturer-sponsored copay contributions.
- Increasing transparency around 340B drug discount program utilization by hospitals.
- Applying Medicare rates to certain highly concentrated hospital markets.
- Repealing shared savings incentives from the Medicare Shared Savings Program.
- Expanding coverage of telehealth services under Medicare.
- Exempting certain value-based arrangements and technologies from Stark Law and Anti-Kickback Statute restrictions.
Overall, the bill aims to increase competition, transparency, and flexibility in the health care system to help reduce costs for consumers.
Committee Categories
Health and Social Services, Military Affairs and Security
Sponsors (1)
Last Action
Referred to the Subcommittee on Health. (on 02/26/2019)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Document Type | Source Location |
---|---|
State Bill Page | https://www.congress.gov/bill/116th-congress/house-bill/1332/all-info |
BillText | https://www.congress.gov/116/bills/hr1332/BILLS-116hr1332ih.pdf |
Bill | https://www.congress.gov/116/bills/hr1332/BILLS-116hr1332ih.pdf.pdf |
Loading...